导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 21.57% | 211/1050 |
| 近一周 | 1.99% | 103/1104 |
| 近一月 | -4.14% | 677/1103 |
| 近一季 | -15.51% | 872/1092 |
| 近半年 | 21.32% | 153/1070 |
| 近一年 | 25.83% | 199/1018 |
| 近两年 | 153.41% | 104/926 |
| 近三年 | 116.89% | 79/834 |
| 成立以来 | 337.73% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.71% 939/1070 |
76.64% 126/1101 |
- - |
- - |
| 2025 | 60.45% 102/1065 |
1.64% 670/1014 |
-0.89% 756/1038 |
57.82% 48/1050 |
0.93% 409/1065 |
| 2024 | 8.97% 315/1011 |
-5.45% 591/960 |
-0.25% 323/983 |
9.39% 670/991 |
5.63% 118/1011 |
| 2023 | -1.27% 121/952 |
17.69% 42/880 |
2.23% 92/895 |
-17.79% 830/915 |
-0.19% 129/952 |
| 2022 | -30.54% 643/867 |
-21.46% 602/773 |
3.53% 607/806 |
-11.13% 311/845 |
-3.88% 600/867 |
| 2021 | 66.09% 3/740 |
-5.60% 367/580 |
41.63% 8/659 |
14.72% 36/704 |
8.29% 117/740 |
| 2020 | 87.55% 69/554 |
8.33% 48/419 |
27.35% 156/466 |
14.55% 152/517 |
18.68% 139/554 |
| 2019 | 64.46% 61/410 |
40.99% 52/1149 |
-1.38% 476/1231 |
8.62% 139/390 |
8.89% 199/410 |
| 2018 | -29.85% 208/349 |
- - |
- - |
- - |
-12.13% 596/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 招商稳健优选股票A VS. 东吴新产业精选股票A(580008) |